GSK loses patent infringement appeal over slow-release Panadol
Intellectual Property May 11, 2018 9:32 pm By Christine Caulfield | Melbourne

A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.